Ignite Creation Date:
2024-05-06 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03512197
Status:
COMPLETED
Last Update Posted:
2023-08-21
First Post:
2018-03-26
Brief Title:
A Global Study of the Efficacy and Safety of Midostaurin Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative FLT3-MN Acute Myeloid Leukemia AML
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CPKC412E2301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None